Publication | Closed Access

Cardiovascular Risk Profile in Kidney Transplant Recipients Treated With Two Immunosuppressive Regimens: Tacrolimus and Mycophenolate Mofetil Versus Everolimus and Low-Dose Cyclosporine

Transplant RejectionUrologyTransplantationCardiovascular DiseaseKidney TransplantKidney TransplantationImmunosuppressive TherapyKidney Transplant RecipientsMedicineNephrologyGraft RejectionCardiovascular Risk ProfileLow-dose Cyclosporine